XML Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$904K Buy
1,170
+85
+8% +$65.1K 0.07% 191
2025
Q4
$838K Sell
1,085
-40
-4% -$27.2K 0.07% 197
2025
Q3
$633K Buy
1,125
+520
+86% +$294K 0.05% 227
2025
Q2
$318K Buy
605
+13
+2% +$7.26K 0.03% 298
2025
Q1
$375K Sell
592
-452
-43% -$311K 0.04% 261
2024
Q4
$744K Sell
1,044
-63
-6% -$52.9K 0.07% 194
2024
Q3
$1.16M Sell
1,107
-100
-8% -$111K 0.11% 158
2024
Q2
$1.27M Sell
1,207
-30
-2% -$29.1K 0.13% 142
2024
Q1
$1.19M Sell
1,237
-20
-2% -$19K 0.12% 151
2023
Q4
$1.1M Buy
1,257
+48
+4% +$39.5K 0.12% 153
2023
Q3
$995K Sell
1,209
-16
-1% -$12.6K 0.12% 152
2023
Q2
$880K Buy
1,225
+61
+5% +$47K 0.1% 170
2023
Q1
$956K Sell
1,164
-90
-7% -$67.9K 0.12% 151
2022
Q4
$905K Sell
1,254
-30
-2% -$22.1K 0.11% 155
2022
Q3
$885K Buy
1,284
+52
+4% +$32.7K 0.12% 149
2022
Q2
$728K Buy
1,232
+160
+15% +$104K 0.16% 110
2022
Q1
$749K Buy
1,072
+89
+9% +$56.3K 0.09% 175
2021
Q4
$621K Sell
983
-20
-2% -$12.3K 0.07% 184
2021
Q3
$607K Buy
1,003
+105
+12% +$65.2K 0.08% 184
2021
Q2
$502K Buy
898
+3
+0.3% +$1.52K 0.11% 143
2021
Q1
$423K Buy
895
+268
+43% +$130K 0.1% 146
2020
Q4
$303K Buy
627
+5
+0.8% +$2.7K 0.08% 163
2020
Q3
$348K Sell
622
-100
-14% -$60.6K 0.11% 140
2020
Q2
$450K Sell
722
-131
-15% -$74.4K 0.16% 107
2020
Q1
$417K Buy
853
+13
+2% +$5.36K 0.18% 99
2019
Q4
$315K Buy
+840
New +$283K 0.11% 136

Other funds holding REGN